Therapeutic Tolerance and Rebound Psychosis During Quetiapine Maintenance Monotherapy in Patients With Schizophrenia and Schizoaffective Disorder (original) (raw)

Introduction. Quetiapine: A 5-Year Update

jeffrey lieberman

The Journal of Clinical Psychiatry, 2002

View PDFchevron_right

High-dose quetiapine in treatment refractory schizophrenia

Julio canel

Schizophrenia …, 2005

View PDFchevron_right

Quetiapine: efficacy and tolerability in schizophrenia

Angela Heiden

European Neuropsychopharmacology, 2001

View PDFchevron_right

Quetiapine in the treatment of schizophrenia and related disorders

Emanuel Severus

Neuropsychiatric Disease and Treatment, 2007

View PDFchevron_right

Antipsychotic Effects of Quetiapine in Naturalistic Long Term Follow Up Study

Se Lim

Psychiatry Investigation, 2010

View PDFchevron_right

Quetiapine: Dose-Response Relationship in Schizophrenia

LESLIE CITROME

Cns Drugs, 2008

View PDFchevron_right

Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study

Ichiro Kusumi, Atsuhito Toyomaki

Annals of general psychiatry, 2015

View PDFchevron_right

Managing acute exacerbations of schizophrenia: focus on quetiapine

Julio Bobes

Current Medical Research and Opinion, 2004

View PDFchevron_right

Quetiapine at high doses for the treatment of refractory schizophrenia

Robert McMahon, Douglas Boggs

Schizophrenia Research, 2008

View PDFchevron_right

Efficacy and Tolerability of Clozapine versus Quetiapine in Treatment-resistant Schizophrenia

Mitesh Kumar

Indian journal of psychological medicine

View PDFchevron_right

Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial

Chi wing Law

BMJ, 2010

View PDFchevron_right

Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder

Stephen Ganocy

The International Journal of Neuropsychopharmacology, 2010

View PDFchevron_right

Quetiapine, an Atypical Antipsychotic

Jessica Goren

1998

View PDFchevron_right

Quetiapine – efficacy in different domains

Tonmoy Sharma

European Neuropsychopharmacology, 2001

View PDFchevron_right

Quetiapine versus typical antipsychotic medications for schizophrenia

Siritree Suttajit

The Cochrane …, 2009

View PDFchevron_right

Quetiapine-induced mania

Giorgio Kotzalidis

Australian and New Zealand Journal of Psychiatry, 2003

View PDFchevron_right

Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

Roberto Cavallaro

Therapeutic Advances in Psychopharmacology, 2013

View PDFchevron_right

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Paul Bergmans, Andreas Schreiner

Neuropsychopharmacology, 2011

View PDFchevron_right

Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders

Emmanuel Stip

International Clinical Psychopharmacology, 2011

View PDFchevron_right

Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospective study

Andreas Carlborg, Teresa Hallerbäck

Therapeutic advances in psychopharmacology, 2012

View PDFchevron_right

Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders

Chang-Jer Tsai

The Kaohsiung Journal of Medical Sciences, 2011

View PDFchevron_right

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial

Emmanuel Stip

Current Medical Research and Opinion, 2006

View PDFchevron_right

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

Andre de nayer

Human Psychopharmacology: Clinical and Experimental, 2005

View PDFchevron_right

Quetiapine: An Objective Evaluation of Pharmacology,Clinical Uses and Intoxication

Ramadhan Oruch

2020

View PDFchevron_right

Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses

Emmanuel Stip

International Clinical Psychopharmacology, 2003

View PDFchevron_right

Antiaggressive Effect of Quetiapine in a Patient With Schizoaffective Disorder

LESLIE CITROME

The Journal of Clinical Psychiatry, 2001

View PDFchevron_right